Buy NantKwest Stock | NK Stock Price & Latest News | Public.com
NK

NantKwest

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View NantKwest (NK) stock trends here

    About NK

    ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.14
    -0.27
    -0.41
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.12

    Actual EPS
    Q2 2021

    Stats

    Market Cap$6,46B
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$45.42
    1 Year Low$2.92
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app